ArticleNPJ breast cancer2023

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients.

Marjolijn M Ladan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.